Skip to content

Migraine in menstrual period

Evaluation of acetazolamide efficacy in migraine headaches in menstrual period

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161103030680N8
Enrollment
100
Registered
2018-02-11
Start date
2013-08-12
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Migraine headaches. Condition 2: Migraine headaches. Migraine without aura (common migraine) Migraine with aura (classic migraine)

Interventions

Intervention 1: Control group:Fifty patients with migraine headaches which is aggravated during menstrual periods take Nortriptiline 0.6 milligrams / kilogram at night and Propranolol one milligrams /

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Migraine headaches according to International headache society criteria At least one year history of migraine headaches At least three attacks of headaches in one month Exacerbation of headaches during menstrual periods Age between eighteen to forty-five years old

Exclusion criteria

Exclusion criteria: Use of any other drugs at the beginning of study Other types of headaches or facial pain Intolerance or allergy to drugs which are used in study Abnormal neurologic exam which is unacceptable in migraine Menstrual period shorter than five days

Design outcomes

Primary

MeasureTime frame
Headache Intensity. Timepoint: Third day after beginning of treatment with acetazolamide and fifth day of menstruation in both groups. Method of measurement: Visual Analougue Scale.;Headache duration. Timepoint: At first day before beginning of treatment and at the end of each treatment episode. Method of measurement: Mean duration of attacks in hour according to patients claims.;Headache Intensity. Timepoint: Third day after beginning of treatment and fifth day of menstruation. Method of measurement: 6 Points Behavioral Rating Scale.;Headache frequency. Timepoint: At first day before beginning of treatment and at the end of each treatment episode. Method of measurement: Number of headache attacks.

Secondary

MeasureTime frame
Allergic drug reactions (Pruritus, Redness of skin, Urticaria). Timepoint: Instantly after alarm of the patient. Method of measurement: Observation, examination and consultation with proper specialist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSiamak Afshinmajd

Shahed University

safshinmajd@gmail.com+98 21 8896 9438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026